The Economist Impact report, supported by Sanofi, argues that respiratory health, particularly the prevention and management of influenza and chronic obstructive pulmonary disease, should be treated as central to ageing policy.
Breathing easy in an ageing Asia-Pacific means fixing a neglected health crisis
March 30, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Alterity strengthens board with seasoned biotech leader as it advances flagship therapy
April 19, 2026 - -
Immuron posts steady global gains as Travelan drives third quarter sales growth
April 19, 2026 - - Australian Biotech -
The 'Dispatched' Week in Review Podcast - 17 April
April 17, 2026 - - Podcast -
New strategic alliance for Biointelect aims to fast track life sciences innovation
April 17, 2026 - - Latest News -
Why hospitals, and not medicines, dominate America’s health spending gap
April 17, 2026 - - Latest News -
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 - - Latest News -
Mark Butler confirms new and expanded cancer medicine listings
April 17, 2026 - - Latest News
